For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Poniard Pharmaceuticals, Inc.

USPTO Granted Patents = 14

% Expired Patents = 92.9

Forward Citations = 38

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Alan R Fritzberg (7 out of 53 patents)

Sudhakar Kasina (4 out of 50 patents)

David A Karlin (4 out of 5 patents)

4. Hazel B Breitz (4 out of 4 patents)

5. Paul L Weiden (4 out of 4 patents)

6. Kent R Thoelke (3 out of 6 patents)

7. James Kyle Bryan (3 out of 6 patents)

8. Mark D Hylarides (3 out of 12 patents)

9. Elizabeth K John (3 out of 6 patents)

10. Lauren Marie Tatalick (3 out of 12 patents)

11. Paul G Abrams (2 out of 19 patents)

12. David John Grainger (1 out of 42 patents)

13. John M Reno (1 out of 45 patents)

14. James C Metcalfe (1 out of 20 patents)

15. Jonathan F Tait (1 out of 10 patents)

14 patents: Sort by Forward Citations

1. 8178564 - Use of picoplatin to treat colorectal cancer (2012-05-15),

2. 8173686 - Use of picoplatin to treat colorectal cancer (2012-05-08),

3. 8168662 - Use of picoplatin to treat colorectal cancer (2012-05-01),

4. 8168661 - Use of picoplatin to treat colorectal cancer (2012-05-01),

5. 7744853 - Radiolabeled annexins (2010-06-29),

6. 7696331 - High dose radionuclide complexes for bone marrow treatment (2010-04-13),

7. 7691985 - Skeletal-targeted radiation to treat bone-associated pathologies (2010-04-06),

8. 7674886 - Bridged aromatic substituted amine ligands with donor atoms (2010-03-09),

9. 7605239 - Skeletal-targeted radiation to treat bone-associated pathologies (2009-10-20),

10. 7511070 - Compounds and therapies for the prevention of vascular and non-vascular pathologies (2009-03-31),

11. 7408046 - Treatment of bone-associated cancers (2008-08-05),

12. 7385042 - Therapeutic and diagnostic compounds, compositions, and methods (2008-06-10),

13. 7378077 - High dose radionuclide complexes for bone marrow suppression (2008-05-27),

14. 7268220 - Bridged aromatic substituted amine ligands with donor atoms (2007-09-11),

Poniard Pharmaceuticals, Inc. is a biotechnology company based in Seattle, WA, focused on the development of innovative cancer therapies. The company specializes in the research and commercialization of targeted treatments aimed at improving patient outcomes in oncology. Poniard is dedicated to advancing its proprietary drug candidates through clinical development, leveraging its expertise in molecular biology and pharmacology to address unmet medical needs in cancer care.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

14 Patents

#137 in Seattle, WA

#483 in Washington

#22,302 in US

#42,199 in the World

Seattle, WA, United States of America

Poniard Pharmaceuticals, Inc.

Forward Citations = 38

15 inventors:

Alan R Fritzberg (7 out of 53 patents)

Sudhakar Kasina (4 out of 50 patents)

David A Karlin (4 out of 5 patents)

4. Hazel B Breitz (4 out of 4 patents)

5. Paul L Weiden (4 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…